90
|
MultiTarget Pharmaceuticals
alzheimer’s disease, the “one-molecule, onetarget” paradigm, and the multitarget directed ligand approach Alzheimer’s Disease, The “One Molecule, Onetarget” Paradigm, And The Multitarget Directed Ligand Approach, supplied by MultiTarget Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/alzheimer’s disease, the “one-molecule, onetarget” paradigm, and the multitarget directed ligand approach/product/MultiTarget Pharmaceuticals Average 90 stars, based on 1 article reviews
alzheimer’s disease, the “one-molecule, onetarget” paradigm, and the multitarget directed ligand approach - by Bioz Stars,
2026-04
90/100 stars
|
Buy from Supplier |